Hormonal stability depends on metabolic steadiness
10.1007/s00125-016-3874-y Diabetologia 19 GautronL.ElmquistJ
Currently available GLP-1 receptor agonists in the UK include: For type 2 diabetes : semaglutide (Ozempic [injection], Rybelsus [oral tablet]), dulaglutide (Trulicity), liraglutide (Victoza), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia) For weight management : semaglutide 2.4 mg (Wegovy) and liraglutide 3 mg (Saxenda) Most GLP-1 medications are administered via subcutaneous injection, with dosing frequencies ranging from daily to once weekly depending on the specific formulation
The medication comes from licensed 503A compounding pharmacies and is available in all 50 states without insurance requirements or membership fees
Personal Opinion: For stubborn elbow tendinopathy that has resisted other treatments, the BPC-157 and TB-500 combination represents a logical escalation
What is the glucose and A1c reduction in non-diabetics & prediabetics